Forte Biosciences Inc (FBRX) — Financial Flexibility Index
Forte Biosciences Inc (FBRX) has a Financial Flexibility Index of -1.07x as of September 2025. Free cash flow of $-13.95 Million (operating CF $-14.00 Million minus capex $55.00K) represents -1% of total liabilities ($12.99 Million). Check strategic asset allocation of Forte Biosciences Inc to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Forte Biosciences Inc Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for Forte Biosciences Inc across 10 annual periods. See Forte Biosciences Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Forte Biosciences Inc (2015–2024)
Year-by-year free cash flow to debt coverage for Forte Biosciences Inc. For the full company profile including market capitalisation, see Forte Biosciences Inc stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.38x | $-30.71 Million | $-30.75 Million | $9.08 Million | ▲ +56.7% |
| 2023 | -7.81x | $-28.62 Million | $-28.71 Million | $3.67 Million | ▼ -203.2% |
| 2022 | -2.57x | $-8.19 Million | $-8.19 Million | $3.18 Million | ▲ +72.8% |
| 2021 | -9.45x | $-16.62 Million | $-16.68 Million | $1.76 Million | ▼ -15.9% |
| 2020 | -8.16x | $-18.42 Million | $-18.42 Million | $2.26 Million | ▼ -497.7% |
| 2019 | -1.36x | $-2.61 Million | $-2.77 Million | $1.91 Million | ▼ -88.7% |
| 2018 | -0.72x | $-32.50 Million | $-34.47 Million | $44.94 Million | ▲ +50.2% |
| 2017 | -1.45x | $-30.48 Million | $-31.13 Million | $20.99 Million | ▼ -41.9% |
| 2016 | -1.02x | $-29.01 Million | $-29.54 Million | $28.36 Million | ▼ -13.5% |
| 2015 | -0.90x | $-20.81 Million | $-21.04 Million | $23.09 Million | — |